In the past, many epilepsy providers have focused solely on seizure control as a way to improve developmental outcomes and HRQOL; however, we now know that the most effective treatment for pediatric epilepsy is comprehensive.
A recently published report describes the case of a 16-year-old male patient who experienced a breakthrough seizure following ingestion of an energy drink and highlights the importance of recognizing drug-herb interactions and properly counseling patients on them.
Zogenix announced the submission of a New Drug Application to the FDA for Fintepla oral solution for the treatment of seizures associated with Dravet syndrome.
In patients with drug-resistant temporal lobe epilepsy, rapid seizure spread outside anteromedial temporal resection resective margins can influence surgical failure, according to study results published in JAMA Neurology. Researchers from Yale University conducted a retrospective review of medical records from 131 patients who underwent standard anteromedial temporal resection at an epilepsy center. Only patients with…
Levetiracetam Injection, an antiepileptic, is indicated as adjunct therapy in patients aged ≥16 years with partial onset seizures, myoclonic seizures in patients with juvenile myoclonic epilepsy, and primary generalized tonic-clonic seizures, when oral administration is temporarily not feasible.
Investigators surveyed adults with tuberous sclerosis complex to evaluate their perception of disease severity, presence of anxiety and depression, and the use and barriers toward mental health services.
Researchers used readily available clinical parameters to determine risk for prolonged status epilepticus at seizure onset, and to predict which patients they anticipated might experience a full recovery.
As treatment with vigabatrin may be associated with permanent vision loss, the generic tablets are also part of a single shared-system Risk Evaluation and Mitigation Strategy (REMS) program to ensure the product is used safely.
